Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression.

Abi Zeid Daou M, Boyd BD, Donahue MJ, Albert K, Taylor WD.

J Affect Disord. 2017 Jun;215:103-110. doi: 10.1016/j.jad.2017.03.027. Epub 2017 Mar 16.

PMID:
28324779
2.

Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.

Zhang X, Tang Y, Maletic-Savatic M, Sheng J, Zhang X, Zhu Y, Zhang T, Wang J, Tong S, Wang J, Li Y.

J Affect Disord. 2016 Sep 1;201:153-61. doi: 10.1016/j.jad.2016.05.014. Epub 2016 May 12.

PMID:
27235818
3.

Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.

Segal ZV, Walsh KM.

Curr Opin Psychiatry. 2016 Jan;29(1):7-12. doi: 10.1097/YCO.0000000000000216. Review.

4.

Imaging predictors of remission to anti-depressant medications in major depressive disorder.

Chi KF, Korgaonkar M, Grieve SM.

J Affect Disord. 2015 Nov 1;186:134-44. doi: 10.1016/j.jad.2015.07.002. Epub 2015 Jul 21. Review.

PMID:
26233324
5.

Large-Scale Persistent Network Reconfiguration Induced by Ketamine in Anesthetized Monkeys: Relevance to Mood Disorders.

Lv Q, Yang L, Li G, Wang Z, Shen Z, Yu W, Jiang Q, Hou B, Pu J, Hu H, Wang Z.

Biol Psychiatry. 2016 May 1;79(9):765-75. doi: 10.1016/j.biopsych.2015.02.028. Epub 2015 Feb 27.

PMID:
25837427
6.

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.

Furey ML, Drevets WC, Szczepanik J, Khanna A, Nugent A, Zarate CA Jr.

Int J Neuropsychopharmacol. 2015 Mar 28;18(8). pii: pyv028. doi: 10.1093/ijnp/pyv028.

7.

Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.

Zanetti MV, Otaduy MC, de Sousa RT, Gattaz WF, Busatto GF, Leite CC, Machado-Vieira R.

Int J Neuropsychopharmacol. 2014 Oct 31;18(6). pii: pyu058. doi: 10.1093/ijnp/pyu058.

8.

Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.

Yuen GS, Gunning FM, Woods E, Klimstra SA, Hoptman MJ, Alexopoulos GS.

J Affect Disord. 2014 Sep;166:179-86. doi: 10.1016/j.jad.2014.05.008. Epub 2014 May 22.

9.

Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis.

Ma Y.

Mol Psychiatry. 2015 Mar;20(3):311-9. doi: 10.1038/mp.2014.24. Epub 2014 Mar 25. Review.

PMID:
24662929
10.

Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.

Heller AS, Johnstone T, Peterson MJ, Kolden GG, Kalin NH, Davidson RJ.

JAMA Psychiatry. 2013 Nov;70(11):1181-9. doi: 10.1001/jamapsychiatry.2013.2430.

11.

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA Jr.

Bipolar Disord. 2014 Mar;16(2):119-28. doi: 10.1111/bdi.12118. Epub 2013 Sep 18.

12.

Understanding the neuropsychiatric consequences associated with significant traumatic brain injury.

Bhalerao SU, Geurtjens C, Thomas GR, Kitamura CR, Zhou C, Marlborough M.

Brain Inj. 2013;27(7-8):767-74. doi: 10.3109/02699052.2013.793396. Review.

PMID:
23789861
13.

Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression.

Disabato BM, Morris C, Hranilovich J, D'Angelo GM, Zhou G, Wu N, Doraiswamy PM, Sheline YI.

Am J Geriatr Psychiatry. 2014 Oct;22(10):1039-46. doi: 10.1016/j.jagp.2013.02.005. Epub 2013 Jun 12.

14.

Monoamine neurocircuitry in depression and strategies for new treatments.

Hamon M, Blier P.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Review.

PMID:
23602950
15.

Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment.

Heller AS, Johnstone T, Light SN, Peterson MJ, Kolden GG, Kalin NH, Davidson RJ.

Am J Psychiatry. 2013 Feb;170(2):197-206. doi: 10.1176/appi.ajp.2012.12010014.

16.

Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment.

Arnone D, McKie S, Elliott R, Thomas EJ, Downey D, Juhasz G, Williams SR, Deakin JF, Anderson IM.

Am J Psychiatry. 2012 Aug;169(8):841-50. doi: 10.1176/appi.ajp.2012.11121774.

PMID:
22854930
17.

Neural expression of nicotine's antidepressant properties during tryptophan depletion: an EEG study in healthy volunteers at risk for depression.

Knott V, Thompson A, Shah D, Ilivitsky V.

Biol Psychol. 2012 Oct;91(2):190-200. doi: 10.1016/j.biopsycho.2012.06.002. Epub 2012 Jun 25.

PMID:
22743591
18.

Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder.

Light SN, Heller AS, Johnstone T, Kolden GG, Peterson MJ, Kalin NH, Davidson RJ.

Biol Psychiatry. 2011 Nov 15;70(10):962-8. doi: 10.1016/j.biopsych.2011.06.031. Epub 2011 Aug 25.

19.

Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.

Brühl AB, Jäncke L, Herwig U.

Psychopharmacology (Berl). 2011 Aug;216(3):389-99. doi: 10.1007/s00213-011-2227-2. Epub 2011 Feb 26.

PMID:
21359508
20.

Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression.

Di Simplicio M, Norbury R, Harmer CJ.

Mol Psychiatry. 2012 May;17(5):503-10. doi: 10.1038/mp.2011.16. Epub 2011 Mar 1.

PMID:
21358707

Supplemental Content

Loading ...
Support Center